C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/10/2004	EP0986754A4 Synthetic antibiotics
11/10/2004	EP0975742B1 Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins
11/10/2004	EP0975660B1 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN alpha-CATENIN and beta-CATENIN
11/10/2004	EP0836611A4 Sequences for production of 2,4-diacetylphloroglucinol and methods
11/10/2004	EP0760852B1 Immunosuppressant target proteins
11/10/2004	CN1545552A Genes and proteins, and their uses
11/10/2004	CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004	CN1545521A Peptide as antagonist of VEGF receptor Flt-1
11/10/2004	CN1545424A Anti-cancer medicine comprising disintegrin genes and treating methods thereof
11/10/2004	CN1544945A Inhibition of Tau-Tau-association
11/10/2004	CN1544634A Plant low-phosphorus resistant genes, encoded protein and application thereof
11/10/2004	CN1544633A Plant low-kalium resistant genes, encoded protein and application thereof
11/10/2004	CN1544632A Gene associated with plant salt resistance and drought resistance, encoded protein and application thereof
11/10/2004	CN1544631A Dehydrin gene BcDh2 and the application of promoter in cultivation of drought resistant plants
11/10/2004	CN1544630A Method for preparing recombinant duck interleukin-2 protein and its application
11/10/2004	CN1544629A Method for preparing recombinant goose interleukin-2 protein and its application
11/10/2004	CN1544470A Bovine serum albumin hot ethanol extracting process
11/10/2004	CN1544469A Anticoagulation raticide immunogen synthesis method
11/10/2004	CN1544468A Polyethylene glycol-interferon connected with amido bond and its making method and uses
11/10/2004	CN1544467A Variable region gene of high neutralization activity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544466A Variable region gene of high affinity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544465A Protein for promoting nerve differentiation and resisting cell death, and its coding gene
11/10/2004	CN1544464A Peptides
11/10/2004	CN1544463A Screening for liver cancer metastasis related protein molecule CK19 and its uses
11/10/2004	CN1544462A Heterologous expression of neisserial proteins
11/10/2004	CN1544461A Uro-genital condition treatment system
11/10/2004	CN1544084A Prolonged delivery of peptides
11/10/2004	CN1175460C Plasma display panel device and method of fabricating the same
11/10/2004	CN1175111C Method for integrating genes at specific sites in mammalian cells and vector used in it
11/10/2004	CN1175109C Expression system for producing recombined human erythrogenin, method for purifying secreted human erythrogenin
11/10/2004	CN1175105C Purification of vitamin-K dependent proteins by membrane chromatography
11/10/2004	CN1175102C Preparation of alpha-1 antichymotrypsin
11/10/2004	CN1174998C Peptide immunogens for prevention and treatment of allergy
11/10/2004	CN1174997C Terminal blocked pentahelicoprotein and its use
11/10/2004	CN1174996C Inhibitor and stimulator of stem cell proliferation and use thereof
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174753C Improved copolymer-1 composed of copolymers
11/10/2004	CN1174742C Controlled release of metal cation-stabilized interferon
11/09/2004	US6815581 Plants which synthesize a modified starch, process for the production thereof and modified starch
11/09/2004	US6815578 For modulating expression of saccharomyces rad50 gene in transgenic plants; genetic engineering
11/09/2004	US6815577 Method of hybrid seed production using conditional female sterility
11/09/2004	US6815575 For identifying genes that prevent cell/tissue (neural, muscle, mesoderm, kidney) degradation/apoptosis using transgenic drosophila
11/09/2004	US6815539 For drug screening potassium channel (slo3) modulators/detection of homologs
11/09/2004	US6815538 Human secreted proteins and polynucleotides encoding the same
11/09/2004	US6815535 Purification of fibrinogen
11/09/2004	US6815531 For diagnosis/therapy of autoimmune diseases; antitumor agents; drugs; cytotoxic t-lymphocytes
11/09/2004	US6815431 Delivering a neurotrophic formulation comprising a neurotrophin encoding lentiviral expression vector, into one or more delivery sites within a region of the brain containing targeted neurons expressed for therapy of brain disorder
11/09/2004	US6815430 Gene expression base sequences for therapeutic use and drugs for gene therapy
11/09/2004	US6815427 Sericin-containing material, process for producing the same method of using the same
11/09/2004	US6815423 Fluorescent substance P
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6815418 Administering transforming growth factor(tgf)-alpha polypeptides, related polypeptides, and mimetics thereof to stimulate proliferation of insulin producing cells
11/09/2004	US6815415 Diagnosis and treatment of malignant neoplasms
11/09/2004	US6815414 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
11/09/2004	US6815201 HIV-1 gp120 V1/V2 domain epitopes capable of generating neutralizing antibodies
11/09/2004	US6815196 Nucleic acids coding enzymatic polypeptide for use in the generation of amino acids for use in animal nutrients
11/09/2004	US6815187 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway
11/09/2004	US6815184 Generating preferential polypeptide in plant; obtain plant cells, transform with vector containing preferential polypeptide, express vector, recover polypeptide
11/09/2004	US6815182 For diagnosis/therapy/prophyaxis of infections/diseases; vaccines; genetic engineering
11/09/2004	US6815181 Nucleic acid molecules encoding human secreted hemopexin-related proteins
11/09/2004	US6815180 Human cervical cancer 1 protooncogene and protein encoded therein
11/09/2004	US6815171 Two-domain mhc polypeptides include mhc( major histocompatibility complex) class ii-based molecules that covalently linked beta 1 and alpha 1 domains, and mhc class i-based molecules that covalently linked alpha-1 and alpha-2
11/09/2004	US6815169 Identification and expression of a novel kinesin motor protein
11/09/2004	US6815168 For use in diagnosis/drug design/therapy; bioassays; solid phase synthesis; for reducing triglycerides/cholesterol levels
11/09/2004	US6815166 HIN-1, a tumor suppressor gene
11/09/2004	US6815159 Generation of viral protease; obtain polypeptide, incubate with chaotropic agent, fold, recover protease
11/09/2004	US6815158 Evaluation of cattle sensitivity to blood disorders; obtain tissue sample, recover major histocompatibility complex protein, detect valine, glutamine and arginine at specific position, presence indicates resistance to blood defect
11/09/2004	US6815063 Magnetic fluid
11/09/2004	US6814970 Present on the surface of borrelia burgdorferi cells that lack the outer membrane proteins ospa, ospb, ospc and ospd; sensitive to cleavage with proteinase k; having binding affinity for certain monoclonal antibodies
11/09/2004	US6814969 Epitopes recognized by t-cells (cd-8/cd-4 antigens) derived from herpetic lesions; fusion proteins; antigen presenting cells; vaccines
11/09/2004	US6814968 Inhibition of viral infection and spread with viral and RhoA-derived peptides
11/09/2004	US6814967 Polypeptides
11/09/2004	US6814965 Methods of decreasing ZVEGF3 activity
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	US6814951 High levels of acetaldehyde and production of malondialdehyde following alcohol ingestion chemically combine in a synergistic manner creating a new hybrid adduct formed with hepatic proteins
11/09/2004	CA2441677A1 Peptides and mixtures thereof for detecting antibodies to severe acute respiratory syndrome-associated coronavirus
11/09/2004	CA2428443A1 Peptides and mixtures thereof for detecting antibodies to severe acute respiratory syndrome-associated coronavirus
11/09/2004	CA2343358C Cerebral organic anion transporter and its gene
11/09/2004	CA2304437C Process for the production of naturally folded and secreted proteins
11/09/2004	CA2273080C Mutants of the lag-3 proteins, products for the expression of these mutants and use
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/09/2004	CA2078985C Influenza virus vaccine composition having a synergic effect and containing influenza virus core as an additive
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004094671A2 Methods and products for identification and assessment of tlr ligands
11/04/2004	WO2004094651A2 Novel human polypeptides encoded by polynucleotides
11/04/2004	WO2004094641A2 A novel method of modulating bone-realted activity
11/04/2004	WO2004094639A2 Recombinant fel d 1 allergen
11/04/2004	WO2004094637A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	WO2004094622A2 Extracellular messengers
11/04/2004	WO2004094621A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof
11/04/2004	WO2004094620A2 Truncated baff receptors
11/04/2004	WO2004094617A2 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use
11/04/2004	WO2004094615A2 Prokaryotic collagen-like proteins and uses thereof
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094610A2 Wnt as a factor for cardiac myogenesis
11/04/2004	WO2004094608A2 Human procolipase like nucleic acids and polypeptides and their methods of use threof
11/04/2004	WO2004094604A2 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004	WO2004094602A2 Combinatorial surface chip compositions for selection, differentiation and propagation of cells
11/04/2004	WO2004094600A2 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
11/04/2004	WO2004094598A2 Methods of use for novel human polypeptides encoded by polynucleotides

1 ... 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 ... 2916